JONLYN MCGETTIGAN: Open Payments
NPI 1629468111 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 28 payments from 14 companies in 2025. Trend: 2023 $751 · 2024 $585 · 2025 $771
Food & beverage: $572Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $143 |
| AstraZeneca Pharmaceuticals LP | 5 | $130 |
| Daiichi Sankyo Inc. | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| ABBVIE INC. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Gilead Sciences, Inc. | 2 | $43 |
| ARRAY BIOPHARMA INC | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
Products named: ERLEADA, ENHERTU, KISQALI, EPKINLY, OJJAARA, LYNPARZA, Trodelvy, LIBTAYO.
Industry payments across AZ — which companies pay providers there.
